- Home
- RCON vs ATNM Comparison
RCON vs ATNM Comparison
Compare RCON & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- ATNM
- Stock Information
- Founded
- RCON 2007
- ATNM 2000
- Country
- RCON China
- ATNM United States
- Employees
- RCON N/A
- ATNM N/A
- Industry
- RCON Oilfield Services/Equipment
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- ATNM Health Care
- Exchange
- RCON Nasdaq
- ATNM Nasdaq
- Market Cap
- RCON 45.3M
- ATNM 51.5M
- IPO Year
- RCON 2009
- ATNM N/A
- Fundamental
- Price
- RCON $2.08
- ATNM $1.54
- Analyst Decision
- RCON
- ATNM Strong Buy
- Analyst Count
- RCON 0
- ATNM 3
- Target Price
- RCON N/A
- ATNM $4.67
- AVG Volume (30 Days)
- RCON 19.3K
- ATNM 229.8K
- Earning Date
- RCON 06-27-2025
- ATNM 05-09-2025
- Dividend Yield
- RCON N/A
- ATNM N/A
- EPS Growth
- RCON N/A
- ATNM N/A
- EPS
- RCON N/A
- ATNM N/A
- Revenue
- RCON $8,996,572.00
- ATNM N/A
- Revenue This Year
- RCON N/A
- ATNM N/A
- Revenue Next Year
- RCON $12.17
- ATNM N/A
- P/E Ratio
- RCON N/A
- ATNM N/A
- Revenue Growth
- RCON N/A
- ATNM N/A
- 52 Week Low
- RCON $1.32
- ATNM $1.03
- 52 Week High
- RCON $3.70
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- RCON 52.90
- ATNM 49.81
- Support Level
- RCON $1.90
- ATNM $1.56
- Resistance Level
- RCON $2.39
- ATNM $1.69
- Average True Range (ATR)
- RCON 0.18
- ATNM 0.11
- MACD
- RCON 0.02
- ATNM -0.01
- Stochastic Oscillator
- RCON 42.13
- ATNM 32.18
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.